Original Articles
Copyright ©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 377-380
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.377
Figure 1
Figure 1 Construction of HBV-specific ribozyme gene (RZ), its recombinant with HDV cDNA (DVRZ) and target DNA (BVCF) by PCR. a: Lane 1: PCR marker, Lane 2: ribozyme gene RZ (53 bp). b: Lane 1: λDNA/Hind III + EcoR I marker, Lane 2: recombinant DVRZ (1682 bp), Lane 3: target gene BVCF (831 bp).
Figure 2
Figure 2 In vitro transcription of linearized pTA-RZ, pTA-DVRZ and pTA-BVCF (Lane 1: rDVRZ, 1782 nt. Lane 2: rBVCF, 931 nt. Lane 3: rRZ, 153 nt).
Figure 3
Figure 3 Cleavage of target RNA (rBVCF) catalyzed by rRZ and rDVRZ. a: Cleavage of target RNA (rBVCF) by rRZ under 37 °C, 42 °C and 55 °C with 20 mmol/L Mg2+. b: Cleavage of target RNA (rBVCF) by rDVRZ under 37 °C, 42 °C and 55 °C with 20 mmol/L Mg2+. c: Cleavage of target RNA (rBVCF) separately by rRZ and rDVRZ at 37 °C under different Mg2+ concentrations (10 mmol/L, 15 mmol/L) (Lane 1, 2: cleavage by rRZ separately under 10 and 15 mmol/L Mg2+; Lane 3, 4: cleavage by rDVRZ separately under 10 and 15 mmol/L Mg2+)